PHILADELPHIA, June 16, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that the arbitration proceeding between Hemispherx and Laboratorios del Dr. Esteve ("Esteve") has been settled and is being dismissed by mutual agreement of the parties.
